Orpea S.A.
Orpea S.A. (ORRRY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
orrry · pe ratio · data through Dec 31, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Orpea S.A. (ORRRY) measures how much investors pay for each dollar of the company's trailing earnings. ORRRY's current PE ratio of N/A is calculated by dividing its stock price of $0.30 by its TTM earnings per share of -$1.82.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31
PE Ratio History
2004 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 19 fiscal years · Front-end computedMinQ1 · 25%0.2x
MedianQ3 · 75%0.8x
Max
At N/A, ORRRY's current P/E is lower than in 0% of its annual fiscal year readings over the past 19 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Orpea S.A.You ORRRY | $372M | N/A | — | -$1.82 |
 biote Corp. BTMD | $103M | 3.01x | -85.0% | $0.86 |
 NIOX Group Plc CSSPF | $274M | 40.40x | +101.2% | $0.02 |
 Dong Fang Hui Le Inc. DFHL | $400M | N/A | — | -$0.00 |
 Guerbet S.A. GUERF | $281M | 16.84x | -16.2% | $1.28 |
 Heyu Biological Technology Corporation HYBT | $361M | N/A | — | -$0.00 |
 PT Tempo Scan Pacific Tbk PEXXF | $463M | N/A | — | — |
Industry Average 3 peers with valid PE | — | 20.08x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-12-31Latest FY2023 | 0.00x | $848.01 | — | |
2022-12-31 FY2022 | — | $-3116.52 | — | |
2021-12-31 FY2021 | 0.39x | $47.50 | +121.4% | |
2020-12-31 FY2020 | 0.18x | $122.00 | +34.3% | |
2019-12-31 FY2019 | 0.13x | $178.50 | -2.3% | |
2018-12-31 FY2018 | 0.14x | $170.50 | -55.2% | |
2017-12-31 FY2017 | 0.30x | $72.90 | +156.1% | |
2016-12-31 FY2016 | 0.12x | $212.85 | -48.7% | |
2015-12-31 FY2015 | 0.23x | $105.95 | +9.4% | |
2014-12-31 FY2014 | 0.21x | $104.00 | +13.7% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Orpea S.A. (ORRRY) measures how much investors pay for each dollar of the company's trailing earnings. ORRRY's current PE ratio of N/A is calculated by dividing its stock price of $0.30 by its TTM earnings per share of -$1.82.
Frequently asked questions
ORRRY pe ratio · 6 questionsORRRY's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.30 and TTM EPS of -$1.82. Data sourced from Financial Modeling Prep via ORRRY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Orpea S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09